Drug recall · April 1, 2020
Tacrolimus Capsules recall
Why: Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2047-01
- Lots / codes
Lot # 3105410, 3106268, Exp 9/2020
- Quantity
- 3,816 botlles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- U.S.A. Nationwide
- Initiated
- March 23, 2020 · Voluntary: Firm initiated
- Classified
- March 24, 2020
- Reported
- April 1, 2020
- Ended
- July 7, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tacrolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.